ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.738,81
-0,72%
S&P 500
5.297,10
-0,21%
Dow Jones
39.869,38
-0,10%
Euro vs US Dollar
1,08596
-0,07%
Bitcoin
65.659,10
0,64%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Editas Medicine Inc (EDIT)

  7. Editas Medicine Inc (EDIT) News

EDIT

Editas Medicine (EDIT)

Editas Medicine Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:EDIT
DatumZeitQuelleÜberschriftSymbolFirma
10/05/202412h00GlobeNewswire Inc.Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual MeetingNASDAQ:EDITEditas Medicine Inc
08/05/202422h21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EDITEditas Medicine Inc
08/05/202414h29IH Market NewsU.S. Futures Slightly Dip Amid Corporate Earnings and Quiet Economic Calendar, Oil Prices FallNASDAQ:EDITEditas Medicine Inc
08/05/202413h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EDITEditas Medicine Inc
08/05/202413h00GlobeNewswire Inc.Editas Medicine Announces First Quarter 2024 Results and Business UpdatesNASDAQ:EDITEditas Medicine Inc
02/05/202413h00GlobeNewswire Inc.Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor EventsNASDAQ:EDITEditas Medicine Inc
01/05/202414h00GlobeNewswire Inc.Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell CollaborationNASDAQ:EDITEditas Medicine Inc
22/04/202422h31GlobeNewswire Inc.Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual MeetingNASDAQ:EDITEditas Medicine Inc
06/03/202402h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
06/03/202402h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
06/03/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
06/03/202401h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
04/03/202423h58Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EDITEditas Medicine Inc
28/02/202423h13Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:EDITEditas Medicine Inc
28/02/202422h39Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:EDITEditas Medicine Inc
28/02/202413h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EDITEditas Medicine Inc
28/02/202413h00GlobeNewswire Inc.Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business UpdatesNASDAQ:EDITEditas Medicine Inc
21/02/202413h00GlobeNewswire Inc.Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor EventsNASDAQ:EDITEditas Medicine Inc
14/02/202414h40Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:EDITEditas Medicine Inc
31/01/202415h00GlobeNewswire Inc.Editas Medicine to Participate in Upcoming Investor ConferencesNASDAQ:EDITEditas Medicine Inc
08/01/202414h15GlobeNewswire Inc.Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare ConferenceNASDAQ:EDITEditas Medicine Inc
03/01/202413h00GlobeNewswire Inc.Editas Medicine to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:EDITEditas Medicine Inc
13/12/202318h48Dow Jones NewsEditas Medicine Strikes License Deal With Vertex Pharmaceuticals -- UpdateNASDAQ:EDITEditas Medicine Inc
13/12/202315h49Dow Jones NewsEditas Medicine Strikes License Deal With Vertex PharmaceuticalsNASDAQ:EDITEditas Medicine Inc
13/12/202315h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EDITEditas Medicine Inc
13/12/202315h00GlobeNewswire Inc.Editas Medicine and Vertex Pharmaceuticals Enter into Non-exclusive License Agreement for Cas9NASDAQ:EDITEditas Medicine Inc
11/12/202322h23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EDITEditas Medicine Inc
11/12/202318h00GlobeNewswire Inc.Editas Medicine Announces New EDIT-301 Safety and Efficacy Data in 17 Patients, Presented Today at the American Society of Hematology (ASH) Annual Meeting and in a Company-sponsored WebinarNASDAQ:EDITEditas Medicine Inc
07/12/202322h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
22/11/202322h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EDITEditas Medicine Inc
 Showing the most relevant articles for your search:NASDAQ:EDIT

Kürzlich von Ihnen besucht

BIT
F15273
Vontobel Financial Produ...
LSE
0RL7
Deutsche Cannabis
ASX
ERJDA
AMEX
ROXA
Series A
BTRX
SERVBTC
EU
0381T
0381T
NYSE
MS-K
Morgan Stanley
LSE
TRST
Trustpilot
ASX
RBTZ
BetaShares Capital
NYSE
CUK
Carnival
TG
A7VA
iMetal Resources
BOV
L1UL34
Lululemon Athletica
BIT
F38926
Vontobel Financial Produ...
USOTC
PLSNF
Plasson Inds (PK)
BITMOT
847269
Imi Opera Iv Sc Mg26 Usd
NASDAQ
ATMVR
AlphaVest Acquisition
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten